These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7619871)

  • 21. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada.
    Strathdee SA; Patrick DM; Archibald CP; Ofner M; Cornelisse PG; Rekart M; Schechter MT; O'Shaughnessy MV
    Addiction; 1997 Oct; 92(10):1339-47. PubMed ID: 9489050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.
    Kivelä PS; Krol A; Partanen AL; Ristola MA
    Scand J Public Health; 2009 Jun; 37(4):357-63. PubMed ID: 19372233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta 2-microglobulin levels in drug users: the influence of risk behaviour.
    Flegg PJ; Brettle RP; Robertson JR; Clarkson RC; Bird AG
    AIDS; 1991 Aug; 5(8):1021-4. PubMed ID: 1777161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relative risk of HIV among IDUs not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences across sexual orientation on HIV risk behaviours in injecting drug users.
    Ross MW; Wodak A; Gold J; Miller ME
    AIDS Care; 1992; 4(2):139-48. PubMed ID: 1606209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.
    Semple SJ; Patterson TL; Grant I
    Drug Alcohol Depend; 2004 Nov; 76(2):203-12. PubMed ID: 15488344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with sexual problems in HIV-positive gay men.
    Cove J; Petrak J
    Int J STD AIDS; 2004 Nov; 15(11):732-6. PubMed ID: 15537458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the law of communicable disease control: compulsory isolation can reduce the high-risk behavior of HIV-positive individuals].
    Sylvan S; Gustavsson M; Christenson B
    Lakartidningen; 1999 Jul; 96(28-29):3244-7. PubMed ID: 10434507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs.
    Braine N; Des Jarlais DC; Goldblatt C; Zadoretzky C; Turner C
    AIDS Educ Prev; 2005 Dec; 17(6):515-24. PubMed ID: 16398574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with changes in sex behaviour among drug users in Puerto Rico.
    Robles RR; Marrero CA; Matos TD; Colón HM; Finlinson HA; Reyes JC; Sahai H
    AIDS Care; 1998 Jun; 10(3):329-38. PubMed ID: 9828976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is sexual serosorting occurring among HIV-positive injection drug users? Comparison between those with HIV-positive partners only, HIV-negative partners only, and those with any partners of unknown status.
    Mizuno Y; Purcell DW; Latka MH; Metsch LR; Ding H; Gomez CA; Knowlton AR
    AIDS Behav; 2010 Feb; 14(1):92-102. PubMed ID: 19308717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-related risk-taking behaviour, knowledge and serostatus of intravenous drug users in Sydney.
    Wolk J; Wodak A; Morlet A; Guinan JJ; Gold J
    Med J Aust; 1990 May; 152(9):453-8. PubMed ID: 2381335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV risk-taking behaviour among amphetamine users in Sydney, Australia.
    Hando J; Hall W
    Addiction; 1994 Jan; 89(1):79-85. PubMed ID: 8148747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sex differences concerning the habit patterns and health among intravenous heroin addicts in Oslo].
    Bretteville-Jensen AL
    Tidsskr Nor Laegeforen; 2000 Jan; 120(2):192-4. PubMed ID: 10851914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users.
    Hestad K; Aukrust P; Ellertsen B; Kløve H; Wilberg K
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):732-42. PubMed ID: 8276932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV risks for women drug injectors: heroin and amphetamine users compared.
    Klee H
    Addiction; 1993 Aug; 88(8):1055-62. PubMed ID: 8401159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users.
    Dolezal C; Meyer-Bahlburg HF; Liu X; Ehrhardt AA; Exner TM; Rabkin JG; Gorman JM; Marder K; Stern Y
    Am J Drug Alcohol Abuse; 1999 May; 25(2):281-303. PubMed ID: 10395161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of interview responses of injecting drug users.
    Ross MW; Stowe A; Wodak A; Gold J
    J Addict Dis; 1995; 14(2):1-12. PubMed ID: 8541354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sources of bias in perception of HIV risk by injecting drug-users.
    Kelaher M; Ross MW
    Psychol Rep; 1992 Jun; 70(3 Pt 1):771-4. PubMed ID: 1620768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.